Comparer des méthodes

	Questionnaire abrégé sur les maladies inflammatoires de l'intestin	Indice de Harvey-Bradshaw
Domaine	Gastro-entérologie	Gastro-entérologie
Famille	Process / pipeline	Process / pipeline
Année d'origine	2004	1980
Auteur d'origine	Guyonnet, D., Chassany, O., Ducroc, R., et al.	R. F. Harvey and J. M. Bradshaw
Type	Self-report	Clinician-rated
Source fondatrice	Guyonnet, D., Chassany, O., Ducroc, R., Picard, C., Mouret, M., D'Haens, G., & Svartz, H. (2004). Effect of fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in France: A multicentre, randomized, double-blind, controlled trial. Alimentary Pharmacology & Therapeutics, 20(4), 459–465.	Harvey, R. F., & Bradshaw, J. M. (1980). A simple index of Crohn's-disease activity. Lancet, 315(8167), 514.
Alias	IBDQ-32, Short IBDQ	HBI
Apparentées	4	5
Résumé	The Short Inflammatory Bowel Disease Questionnaire (IBDQ-32) is a validated patient-reported outcome measure designed to assess the impact of inflammatory bowel disease (IBD)—both ulcerative colitis and Crohn's disease—on health-related quality of life. Derived from the original 32-item IBDQ, this instrument comprises four domains: Bowel Symptoms, Systemic Symptoms, Social Function, and Emotional Function. The IBDQ-32 is responsive to treatment and is increasingly used in IBD clinical trials and practice.	The Harvey-Bradshaw Index (HBI) is a simple, clinician-administered tool for assessing disease activity in Crohn's disease. Developed in 1980, it measures five clinical parameters including abdominal pain, stool frequency, and extraintestinal manifestations. The HBI is widely used in clinical practice and research for monitoring disease progression and treatment response.